NIH-funded research R01 grant

Understanding the role of gut bacteria in Celiac Disease

Official title: Toward parsing gut microbiota-epithelium-immune metabolic crosstalk in Celiac Disease

Funded at Massachusetts General Hospital · NIH-11116924 · Data updated 2026-11-12

This study is looking at how the bacteria in your gut might affect your immune system and the lining of your intestines if you have or are at risk for Celiac Disease, to better understand what role these bacteria play in the disease.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 14, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$599,318
NIH project number5R01AI184777-02
Project IDNIH-11116924 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are genetically predisposed to Celiac Disease or have early signs of the condition.

Less likely to help

Patients who do not have a genetic predisposition to Celiac Disease or are not experiencing any symptoms related to the condition may not benefit from this research.

What this research studies

This research investigates how gut bacteria interact with the immune system and the intestinal lining in individuals with Celiac Disease. By analyzing samples from patients at risk of developing the disease, the study aims to identify specific gut microbes that may contribute to the onset and severity of Celiac Disease. Researchers will use advanced computational models to simulate these interactions and gain insights into the underlying mechanisms of the disease. This approach could help clarify whether changes in gut bacteria are a cause or a result of the disease.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Celiac Disease by targeting gut microbiota.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in autoimmune diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Zomorrodi, Ali R — Massachusetts General Hospital
  • Study coordinator: Zomorrodi, Ali R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.